Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension

By afschroeder • May 16, 2026

Singh N, Lawson J, Ragavendran A, Banerjee S, Hon A, Vega A, Hong J, Mullin CJ, Pereira M, Sherman-Roe A, Jorrin AT, Cayton T, Fishbein G, Klinger JR, Oldham WM, Wang RS, Dai Z, Fallon M, Harrington EO, Liang OD, Umar S, Ventetuolo CE. Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension. Compr Physiol. 2026 Jun;16(3):e70171. doi: 10.1002/cph4.70171. PMID: 42138622; PMCID: PMC13178415.

Tags: endothelial cell, hepatic fibrosis, hepatic growth factor, model for end stage liver disease, Publications, pulmonary arterial hypertension, pulmonary vascular inflammation, Pulmonary, Critical Care & Sleep Medicine, Sugen‐hypoxia

American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults

O'Dwyer K, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer J, Hayes-Lattin[...]

Quality measures in the design, conduct, and reporting of endoscopic research

Elmunzer BJ, Madhoun M, Cote GA, Cummings LC, Shahidi N, Srivastava N, Essex EA, Scheiman JM, May FP, Yen T, Barkun A, Durkalski-Mauldin V, Dominitz[...]

Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3 Possible Approaches

Kanzaki Y, Morishima I, Mori S, Shimojo K, Tanaka Y, Yamada T. Premature Ventricular Contractions Ablated via the Left Ventricular Annular Vein: Demonstration of 3[...]